|
Affiliation |
Faculty of Medicine College Hospital Intensive care part |
|
Title |
Associate Professor |
|
External Link |
|
TANIGUCHI Masahiko
|
|
|
Degree 【 display / non-display 】
-
Doctor (Medicine) ( 1996.3 Miyazaki Medical College )
-
医学（医学） ( 1990.3 宮崎医科大学 )
Papers 【 display / non-display 】
-
Furusawa Takahiro, Yano Takeshi, Kashino Rina, Yoshikai Mizuho, Koshida Tomohiro, Yonaha Tetsu, Taniguchi Masahiko, Tsuneyoshi Isao
Journal of the Japanese Society of Intensive Care Medicine 30 ( 1 ) 23 - 24 2023.1
Language：Japanese Publishing type：Research paper (scientific journal) Publisher：The Japanese Society of Intensive Care Medicine
DOI： 10.3918/jsicm.30_23
-
Comparison of permeability and antithrombotic properties of two Polysulfone (PS) membranes Reviewed
Yamasaki Tatsumi, Adachi Nene, Oda Yuuichi, Yano Takeshi, Taniguchi Masahiko, Shirasaka Tetsuro
Journal of Japan Society for Blood Purification in Critical Care 13 ( 1 ) 64 - 68 2022.6
Language：Japanese Publishing type：Research paper (scientific journal) Publisher：Japan Society for Blood Purification in Critical Care
In recent years, HEMOFEEL<sup>®</sup> SNV, in which an NV polymer is localized on the inner surface of the hollow fiber of a Polysulfone (PS) membrane hemofilter, has been sold. NV polymers are believed to have improved antithrombotic properties by suppressing protein adhesion (fouling). In order to investigate the permeability and antithrombotic properties of HEMOFEEL<sup>®</sup> SNV, we compared it with other companies’ PS membrane hemofilters. The subjects were 56 adult patients who underwent CHDF (continuous hemodiafiltration) using PS membrane hemofilters, and the number of membranes was 226. The patients were divided into the EXCELFLO<sup>®</sup> AEF-13 group and the HEMOFEEL<sup>®</sup> SNV-1.3 group, and the transmembrane pressure (TMP), ultrafiltration rate (UFR), and lifetime were compared. The results suggested that the HEMOFEEL<sup>®</sup> SNV-1.3 group had significantly lower TMP and significantly higher UFR, which was advantageous for high flow rate filtration settings.
-
Investigation of optimal ACT value during continuous hemodiafiltration using nafamostat mesilate
Yamasaki Tatsumi, Oda Yuuichi, Yano Takeshi, Taniguchi Masahiko, Shirasaka Tetsuro
Journal of Japan Society for Blood Purification in Critical Care 12 ( 1 ) 58 - 63 2021.12
Language：Japanese Publishing type：Research paper (scientific journal) Publisher：Japan Society for Blood Purification in Critical Care
Nafamostat mesilate (NM) was a first-choice drug used as an anticoagulant in continuous hemodiafiltration (CHDF) in our hospital. Activated clotting time (ACT) is an index of the dose of NM. The standard value of ACT is undecided, and blood coagulation in the circuit is occasionally observed. The purpose of this study was to investigate the optimal ACT value for continuous hemodiafiltration using NM. Forty-seven adult patients with scheduled CHDF using NM were included in this study. The ACT value of the outlet site (H-ACT) in the circuit of the hemofiltration device and the ACT value of arterial blood (A-HCT) were measured. There are significant differences (<i>P</i>＜ 0.001) in the H-ACT values between the group (346±94.1s) that continued hemodiafiltration for more than 48 hours and the group（261±92.5s）that stopped hemodiafiltration within 48 hours due to occlusion in the dialysis circuit. These results suggest that a higher H-ACT value lowers the risk of occlusion in the circuit. As analyzed by receiver operating characteristic (ROC) analysis, the cut-off value for the achievement of CHDF was 271 sec (specificity 69.6%, sensitivity 85.1%). These results suggest that H-ACT values of more than 271 sec are appropriate.
-
麻酔覚醒時のバッキングが原因と考えられた特発性縦隔気腫の１症例． Reviewed
長嶺佳弘，矢野武志，森 信一郎，内村修二，與那覇 哲，江川久子，谷口正彦，恒吉勇男
麻酔 70 ( 8 ) 866 - 869 2021.8
Language：Japanese Publishing type：Research paper (scientific journal)
-
糖質制限経腸栄養製品により術後肝機能障害を繰り返した１症例． Reviewed
内村修二，谷口正彦，野邊萌子，喜多絵美子，笹葉啓子，恒吉勇男
臨床麻酔 45 ( 2 ) 217 - 219 2021.2
Language：Japanese Publishing type：Research paper (scientific journal)
Books 【 display / non-display 】
-
麻酔偶発症A to Z
谷口正彦（ Role： Contributor , 局所麻酔薬の心毒性．）
文光堂 2017.6
Responsible for pages：477-478 Language：Japanese Book type：Scholarly book
-
麻酔偶発症A to Z
谷口正彦（ Role： Contributor , メトヘモグロビン血症．）
文光堂 2017.6
Responsible for pages：474 Language：Japanese Book type：Scholarly book
-
麻酔科医のための周術期の薬物使用法-ミルリノン
谷口正彦, 恒吉勇男（ Role： Joint author , 全身管理薬ーミルリノン pp208-211）
中山書店 2015.4
Language：Japanese Book type：Scholarly book
-
麻酔科医のための周術期の薬物使用法-イソプレナリン
谷口正彦, 矢野武志, 恒吉勇男（ Role： Joint author , 全身管理薬ーイソプレナリン pp206-208）
中山書店 2015.4
Language：Japanese Book type：Scholarly book
-
集中治療医学講座13，気管切開―最新の手技と管理―
谷口正彦（ Role： Edit , 私のコツ：Blue-Rhino(COOK)）
医学図書出版株式会社 2011.6
Language：Japanese Book type：Scholarly book
MISC 【 display / non-display 】
-
局所麻酔薬とオピオイドの硬膜外投与
谷口 正彦,髙崎 真弓
ペインクリニック 26 S233 - S238 2005.3
Language：Japanese Publishing type：Article, review, commentary, editorial, etc. (scientific journal) Publisher：真興交易
-
腕神経叢ブロックの成功率を上げる方法
谷口 正彦,河野 太郎,與那覇 哲,田村 隆二,丸田 豊明,矢野 武志,大久保 重明,柏田 政利,三浦 弘樹,岩崎 竜馬,松岡 博史,立山 真吾,吉村 安広,成尾 浩明,白阪 哲朗,田中 信彦,指宿 昌一郎,鈴木 宣彰,笠羽 敏治,髙崎 真弓
臨床麻酔 28 ( 6 ) 1081 - 1086 2004.6
Language：Japanese Publishing type：Article, review, commentary, editorial, etc. (scientific journal) Publisher：真興交易
Presentations 【 display / non-display 】
-
人工呼吸器HAMILTON-G5に内蔵された高流量酸素投与機能の使用経験．
村社瑞穂，長嶺佳弘，矢野武志，谷口正彦，恒吉勇男
日本臨床麻酔学会第41回大会
Event date： 2021.11.5 - 2021.11.7
Language：Japanese Presentation type：Oral presentation (general)
-
腹臥位療法後にICU-acquired weaknessを発症した重症COVID-19の１症例．
古澤高廣，矢野武志，村社瑞穂，深尾麻由，與那覇 哲，山下幸貴，谷口正彦，恒吉勇男
日本臨床麻酔学会第41回大会
Event date： 2021.11.5 - 2021.11.7
Language：Japanese Presentation type：Oral presentation (general)
-
透析用ブラッドアクセスカテーテルが上行腰静脈に迷入し腸腰筋血腫を呈した１症例．
古澤高廣，矢野武志，村社瑞穂，深尾麻由，與那覇 哲，山下幸貴，谷口正彦，恒吉勇男
日本集中治療医学会第５回九州支部学術集会
Event date： 2021.7.24
Language：Japanese Presentation type：Oral presentation (general)
-
NutriVentTMを使用し呼吸管理を行った侵襲性肺アスペルギルス症の一例．
村社瑞穂，與那覇 哲，深尾麻由，古澤高廣，越田智広，矢野武志，山下幸貴，谷口正彦
日本集中治療医学会第５回九州支部学術集会
Event date： 2021.7.24
Language：Japanese Presentation type：Oral presentation (general)
-
ECMOの抗凝固剤としてナファモスタットを使用したHIT抗体陽性COVID-19肺炎の１症例（優秀演題）．
與那覇 哲，村社瑞穂，深尾麻由，古澤高廣，越田智広，矢野武志，山下幸貴，谷口正彦，恒吉勇男
日本集中治療医学会第５回九州支部学術集会
Event date： 2021.7.24
Language：Japanese Presentation type：Oral presentation (general)
Grant-in-Aid for Scientific Research 【 display / non-display 】
-
局所麻酔薬の神経毒性とフリーラジカル
2004.04 - 2005.03
科学研究費補助金 若手研究(B)